000 | 01097 a2200301 4500 | ||
---|---|---|---|
005 | 20250513074849.0 | ||
264 | 0 | _c19930720 | |
008 | 199307s 0 0 eng d | ||
022 | _a0041-1345 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKizilisik, T A | |
245 | 0 | 0 |
_aCytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis. _h[electronic resource] |
260 |
_bTransplantation proceedings _cJun 1993 |
||
300 |
_a2282-3 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAcyclovir _xtherapeutic use |
650 | 0 | 4 |
_aCytomegalovirus Infections _xphysiopathology |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aLiver Transplantation _ximmunology |
650 | 0 | 4 |
_aPostoperative Complications _xmicrobiology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aPreiksaitis, J K | |
700 | 1 | _aKneteman, N M | |
773 | 0 |
_tTransplantation proceedings _gvol. 25 _gno. 3 _gp. 2282-3 |
|
999 |
_c8390011 _d8390011 |